Personalized Medicine and Pharmacogenomics represent revolutionary approaches in healthcare that prioritize tailoring medical treatments and drug interventions to an individual's unique genetic makeup. These fields leverage advancements in genomics and molecular biology to customize healthcare decisions, improving treatment efficacy and minimizing adverse effects. In Personalized Medicine, genetic information is utilized to identify a patient's susceptibility to certain diseases, predict treatment responses, and guide preventive measures. This individualized approach enhances precision in diagnostics, allowing for targeted and optimized interventions. Pharmacogenomics focuses on the genetic variations influencing drug responses, helping healthcare providers prescribe medications that are most effective and well-tolerated by a specific patient. This approach minimizes the trial-and-error aspect of drug prescribing, optimizing therapeutic outcomes. By understanding the genetic factors influencing drug metabolism and efficacy, healthcare professionals can tailor drug regimens to match an individual's unique genetic profile. This not only improves treatment outcomes but also reduces the risk of adverse reactions and enhances overall patient safety. The integration of Personalized Medicine and Pharmacogenomics holds immense potential for transforming healthcare into a more precise, efficient, and patient-centered paradigm, ushering in an era where medical interventions are finely tuned to each person's genetic uniqueness.
Title : The impact of AI on the future of public health and preventative healthcare
David John Wortley, International Society of Digital Medicine (ISDM), United Kingdom
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Managing integration and interoperability of intelligent and ethical transformed health and social care ecosystems
Habil Bernd Blobel, University of Regensburg, Germany
Title : Study scalp electroacupuncture therapy for autism spectrum disorder
Zhenhuan Liu, University of Chinese Medicine, China
Title : Environmental Public Health Impact Assessment (EHIA) process for tobacco processing plants
Vijayan Gurumurthy Iyer, Techno-Economic- Environmental Study and Check Consultancy Services, India
Title : Therapeutic potential of Benincasa hispida extract in regulating metabolic markers among patients with type 2 diabetes
Wan Rosli Wan Ishak , University Science Malaysia, Malaysia